213 related articles for article (PubMed ID: 33841567)
1. Construction of
Takahashi N; Higa A; Hiyama G; Tamura H; Hoshi H; Dobashi Y; Katahira K; Ishihara H; Takagi K; Goda K; Okabe N; Muto S; Suzuki H; Shimomura K; Watanabe S; Takagi M
Oncol Lett; 2021 May; 21(5):406. PubMed ID: 33841567
[TBL] [Abstract][Full Text] [Related]
2. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
Takahashi N; Hoshi H; Higa A; Hiyama G; Tamura H; Ogawa M; Takagi K; Goda K; Okabe N; Muto S; Suzuki H; Shimomura K; Watanabe S; Takagi M
Cells; 2019 May; 8(5):. PubMed ID: 31137590
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids.
Higa A; Takahashi N; Hiyama G; Tamura H; Hoshi H; Shimomura K; Watanabe S; Takagi M
J Vis Exp; 2021 Jun; (172):. PubMed ID: 34180908
[TBL] [Abstract][Full Text] [Related]
4. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
6. An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.
Gitto SB; Kim H; Rafail S; Omran DK; Medvedev S; Kinose Y; Rodriguez-Garcia A; Flowers AJ; Xu H; Schwartz LE; Powell DJ; Simpkins F
Gynecol Oncol; 2020 Jan; 156(1):222-232. PubMed ID: 31818495
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
8. Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models.
Tan D; An J; Gong M; Wang H; Li H; Meng H; Zhang C; Zhao Y; Ge X; Shi C
Front Oncol; 2022; 12():1043479. PubMed ID: 36591461
[TBL] [Abstract][Full Text] [Related]
9. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
Gao J; Lan J; Liao H; Yang F; Qiu P; Jin F; Wang S; Shen L; Chao T; Zhang C; Zhu Y
BMC Cancer; 2023 Dec; 23(1):1205. PubMed ID: 38062430
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
Eckhardt BL; Gagliardi M; Iles L; Evans K; Ivan C; Liu X; Liu CG; Souza G; Rao A; Meric-Bernstam F; Ueno NT; Bartholomeusz GA
PLoS One; 2018; 13(5):e0195932. PubMed ID: 29768500
[TBL] [Abstract][Full Text] [Related]
11. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy.
Lin S; Huang G; Cheng L; Li Z; Xiao Y; Deng Q; Jiang Y; Li B; Lin S; Wang S; Wu Q; Yao H; Cao S; Li Y; Liu P; Wei W; Pei D; Yao Y; Wen Z; Zhang X; Wu Y; Zhang Z; Cui S; Sun X; Qian X; Li P
MAbs; 2018; 10(8):1301-1311. PubMed ID: 30204048
[TBL] [Abstract][Full Text] [Related]
12. [Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].
Hamada A
Yakugaku Zasshi; 2020; 140(5):641-648. PubMed ID: 32378664
[TBL] [Abstract][Full Text] [Related]
13. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.
Fong ELS; Toh TB; Lin QXX; Liu Z; Hooi L; Mohd Abdul Rashid MB; Benoukraf T; Chow EK; Huynh TH; Yu H
Biomaterials; 2018 Mar; 159():229-240. PubMed ID: 29353739
[TBL] [Abstract][Full Text] [Related]
14. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.
Ling X; Wu W; Fan C; Xu C; Liao J; Rich LJ; Huang RY; Repasky EA; Wang X; Li F
J Exp Clin Cancer Res; 2018 Oct; 37(1):240. PubMed ID: 30285798
[TBL] [Abstract][Full Text] [Related]
15. Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.
Xiang K; Wang E; Mantyh J; Rupprecht G; Negrete M; Sanati G; Hsu C; Randon P; Dohlman A; Kretzschmar K; Bose S; Giroux N; Ding S; Wang L; Balcazar JP; Huang Q; Sundaramoorthy P; Xi R; McCall SJ; Wang Z; Jiang C; Kang Y; Kopetz S; Crawford GE; Lipkin SM; Wang XF; Clevers H; Hsu D; Shen X
Adv Sci (Weinh); 2024 Apr; 11(16):e2303379. PubMed ID: 38380561
[TBL] [Abstract][Full Text] [Related]
16. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
Kumari R; Xu X; Li HQ
Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Matossian MD; Burks HE; Elliott S; Hoang VT; Bowles AC; Sabol RA; Wahba B; Anbalagan M; Rowan B; Abazeed ME; Bunnell BA; Moroz K; Miele L; Rhodes LV; Jones SD; Martin EC; Collins-Burow BM; Burow ME
BMC Cancer; 2019 Mar; 19(1):205. PubMed ID: 30845999
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma.
Jo EB; Hong D; Lee YS; Lee H; Park JB; Kim SJ
Transl Oncol; 2019 Feb; 12(2):269-281. PubMed ID: 30447641
[TBL] [Abstract][Full Text] [Related]
19. Current status and perspectives of patient-derived xenograft models in cancer research.
Lai Y; Wei X; Lin S; Qin L; Cheng L; Li P
J Hematol Oncol; 2017 May; 10(1):106. PubMed ID: 28499452
[TBL] [Abstract][Full Text] [Related]
20. A Simple Three-Dimensional In Vitro Culture Mimicking the In Vivo-Like Cell Behavior of Bladder Patient-Derived Xenograft Models.
Amaral R; Zimmermann M; Ma AH; Zhang H; Swiech K; Pan CX
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]